Literature DB >> 8738566

Immunolocalizations of human gelatinase (type IV collagenase, MMP-9) and TIMP (tissue inhibitor of metalloproteinases) in normal epidermis and some epidermal tumors.

T Kobayashi1, N Onoda, T Takagi, H Hori, S Hattori, Y Nagai, S Tajima, T Nishikawa.   

Abstract

The matrix metalloproteinases (MMPs) MMP-2 and MMP-9 (gelatinases) have been suggested as serving an important role in cleaving the basement membrane structure. Tissue inhibitors of metalloproteinases TIMPs (particularly TIMP-1) are known to inhibit MMPs. Based on this background, we raised monoclonal antibodies against human gelatinase (MMP-9) and human recombinant TIMP (TIMP-1), and immunostained these two components in skin from patients with squamous cell carcinoma (SCC), Bowen's disease (BD) and keratoacanthoma (KA). MMP-9 showed positive staining mainly in the granular layer of normal epidermis. In some cases of SCC and BD, MMP-9 showed positive staining in the dysplastic lesions even in the basal layer. TIMP showed a thorough positivity in normal epidermis. Unstained regions with this antibody were observed in SCC and BD. These results suggest that an altered staining pattern for MMP-9 and TIMP may be closely related to the malignant transformation of SCC and BD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738566     DOI: 10.1007/bf02530091

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  31 in total

1.  Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices.

Authors:  Y Sarret; D T Woodley; G S Goldberg; A Kronberger; K C Wynn
Journal:  J Invest Dermatol       Date:  1992-12       Impact factor: 8.551

2.  Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface.

Authors:  J C Adams; F M Watt
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

3.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

4.  92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma.

Authors:  M Ståhle-Bäckdahl; W C Parks
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

5.  Type I keratinocyte transglutaminase: expression in human skin and psoriasis.

Authors:  W T Schroeder; S M Thacher; S Stewart-Galetka; M Annarella; D Chema; M J Siciliano; P J Davies; H Y Tang; B A Sowa; M Duvic
Journal:  J Invest Dermatol       Date:  1992-07       Impact factor: 8.551

6.  Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium.

Authors:  Y Okada; Y Gonoji; I Nakanishi; H Nagase; T Hayakawa
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

7.  Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.

Authors:  C Pyke; E Ralfkiaer; P Huhtala; T Hurskainen; K Danø; K Tryggvason
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

8.  Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.

Authors:  G I Goldberg; A Strongin; I E Collier; L T Genrich; B L Marmer
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

9.  Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.

Authors:  H Sato; Y Kida; M Mai; Y Endo; T Sasaki; J Tanaka; M Seiki
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

10.  Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines.

Authors:  M Oishi; K Maeda; S Sugiyama
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

View more
  6 in total

1.  Expression of matrix metalloproteinase-1, -9, -13, and tissue inhibitor of metalloproteinases-1 in basal cell carcinomas of the eyelid.

Authors:  Zornitsa I Zlatarova; Ekaterina B Softova; Klara G Dokova; Elisabeth M Messmer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-01       Impact factor: 3.117

2.  A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization.

Authors:  T Kobayashi; J Kishimoto; Y Ge; W Jin; D L Hudson; N Ouahes; R Ehama; H Shinkai; R E Burgeson
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

3.  The expression of metaloproteinases-2 and -9 is different according to the patterns of growth and invasion in squamous cell carcinoma of the penis.

Authors:  Fernando A Soares; Isabela Werneck da Cunha; Gustavo Cardoso Guimarães; Sueli Nonogaki; Rodrigo Sousa Madeira Campos; Ademar Lopes
Journal:  Virchows Arch       Date:  2006-10-27       Impact factor: 4.064

4.  Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.

Authors:  Thorsten Sadowski; Sebastian Dietrich; Felix Koschinsky; Radislav Sedlacek
Journal:  Mol Biol Cell       Date:  2003-08-22       Impact factor: 4.138

5.  Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk.

Authors:  Hongmei Nan; Tianhua Niu; David J Hunter; Jiali Han
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

6.  Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin.

Authors:  J Varani; Y Hattori; Y Chi; T Schmidt; P Perone; M E Zeigler; D J Fader; T M Johnson
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.